FDA Report Faults St. Jude For Handling Of Heart Device
A portion of the partially redacted report detailed inadequacies in the design process for the Durata defibrillator lead, as determined by an FDA employee during the inspection of the company's Sylmar, Calif., facility in September and October.
The Durata lead replaced St. Jude's Riata lead. The FDA issued its...
To view the full article, register now.